SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bafna Pharmaceuticals soars on clearing renewal of MHRA- UK audit process

03 Mar 2015 Evaluate

Bafna Pharmaceuticals is currently trading at Rs. 27.70, up by 0.95 points or 3.55% from its previous closing of Rs. 26.75 on the BSE.

The scrip opened at Rs. 27.70 and has touched a high and low of Rs. 28.35 and Rs. 26.90 respectively. So far 44887 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 38.50 on 02-Jul-2014 and a 52 week low of Rs. 16.90 on 01-Apr-2014.

Last one week high and low of the scrip stood at Rs. 29.00 and Rs. 24.10 respectively. The current market cap of the company is Rs. 51.86 crore.

The promoters holding in the company stood at 36.95% while Non-Institutions held 63.05% stake in the company.

Bafna Pharmaceuticals has successfully cleared the renewal of audit process as per the guidelines issued by the Medicine and Healthcare Product Agency (MHRA- UK) for European Union GMP.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

145.00 12.40 (9.35%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×